Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARVIVA-HF: carvedilol, ivabradine and their combination in patients with heart failure
2011-002520-40Phase 3Active
- Sponsor
- IRCCS San Raffaele Pisana
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of carvedilol and ivabradine in chronic heart failure (CHF) and Cardiomyopathies (3 arms), sponsored by IRCCS San Raffaele Pisana. Primary endpoints: Exercise time at 6-minute walking test and Maximal oxygen consumption during cardiopulmonary exercise test. Started Mar 2012; status: active.
02
Drugs
carvedilolivabradine
03
Conditions
chronic heart failure (CHF)Cardiomyopathies
Beyond the preview
Go deeper on 2011-002520-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002520-40.